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1INTRODUCTION
The kidneys are highly differentiated organs in our body system. They
perform a variety of complex process in our body to maintain the normal
homeostasis. The kidneys change the concentration of urine ,maintain the
water balance thereby the acid base balance and electrolytes in our body. The
Nitrogeneous products from the protein metabolism and other waste products
produced in the body are excreted by the kidneys. They also produce
hormones like erythropoietin to maintain the haemoglobin concentration and
has a major role in mineral metabolism. Added to the above function, kidneys
play a significant role in elimination of the toxins and drug metabolites. The
most commonly used parameter to assess the renal function  is serum
creatinine.The correlation between GFR and creatinine is confounded by
several factors.Normal GFR range from 90 to 120ml/min/1.73sq.m.
Acute kidney injury is characterised by sudden and rapid impairment of
renal function occurring over a period of hours to days ,resulting in
accumulation of toxic, nitrogeneous substances. Acute Renal Failure term is
restricted to patients presenting with acute kidney injury who needs renal
replacement therapy. Chronic kidney disease is a spectrum of pathological
process characterised by abnormal kidney function and progressive decline in
2glomerular filtration .End stage kidney disease results in accumulation of
toxic metabolites resulting in uremic syndrome. Renal Replacement Therapy
is required when the renal function deteriorates leading to accumulation of
metabolic waste products that interfere with the normal homeostasis.
Haemodialysis is an extracorporeal procedure to remove extra salt ,fluids and
toxins through a dialysis machine. The population of patients undergoing
dialysis is increasing day by day due to high incidence of chronic kidney
disese and AKI. Central venous catheters are frequently used to initiate the
dialysis before the arteriovenous fistulas are mature and starts functioning.
Sepsis related death is more common in dialysis patients than the
general population. Bacteremia complicates the central venous catheter use in
haemodialysis patients. Catheter related infection is suspected based on the
clinical profile of the patients like fever, chills, rigor, unexplained
hypotension, altered mental status, local catheter site abscess, induration
around the exit port site. Catheter related blood stream infection is the most
common indication for the catheter removal. Contamination of skin flora,
unsterile handling of catheter by the training personnel, malnutrition,
Diabetes, malignancy, hypoalbuminemia, increased duration of catheter all
predispose to the high chances of catheter related infection.
3AIM OF THE STUDY
1) To study the incidence of temporary vascular catheter related
infections in haemodialysis patients
2) To study the most common risk factors for catheter infection and to
study about the bacteriological profile of catheter related infection.
4REVIEW OF LITERATURE
Dialysis is a treatment that filters and purifies the blood. Dialysis has
been used since 1940s to treat people with kidney disease. Dialysis is a
process whereby the solute composition in solution A, is altered by exposing
solution A to a second solution B, through a semipermeable membrane. The
semipermeable membrane can be viewed as a sheet perforated by holes or
pores. Water molecules and low molecular weight solutes in the two solutions
can pass through the membrane pores, but larger solutes like proteins cannot
pass through the semipermeable barrier, and the high molecular weight
solutes on either side of the membrane will remain unchanged.
There are two types of dialysis
1)Peritoneal dialysis
2)Haemodialysis
Goals of Dialysis:
The haemodialysis procedure consists of pumping heparinized blood
through the dialyser at a flow rate of 300-500ml/min, the dialysate flows in
opposite counter current direction at 500-800ml/min.
5Dialysis dose is defined by the fractional urea clearance during the dialysis
treatment. It also depends on the patient size, residual renal function,protein
intake and other co-morbidities.
Principles of haemodialysis
Haemodialysis is based on the principles of diffusion and ultrafiltration
across the semipermeable membrane.
Diffusion:
The movement of solutes by diffusion is the result of random molecular
motion. The larger the molecular weight of a solute the slower its rate of
transport across a semipermeable membrane small  molecules, (eg urea 60
Da) moving about at high velocity, will collide with the membrane and their
rate of diffusion transport through the membrane will be high .Large
molecules (e.g creatinine 113 Da) those that can fit easily through the
membrane pores will diffuse through the membrane slowly because they will
be moving about at low velocity and colliding with the membrane
infrequently.
6DIFFUSION
ULTRAFILTRATION
The second mechanism of solute transport across semipermeable
membrane is ultrafiltration (Connective transport). Water molecules are
extremely small and can pass through all semipermeable membranes.
Ultrafiltration occurs when water driven by either a hydrostatic or an osmotic
force is pushed through the membrane. Those solutes that can pass easily
through the membrane pores  are swept along with the water a process called
‘solvent drag’. The water being pushed through the membrane is
7accompanied by such solutes close to their original concentrations. Larger
solutes, especially those that are larger than the membrane pores are held
back. For such large solutes the membrane acts as a sieve.
ULTRA FILTRATION
Components haemodialysis
There are three essential components to haemodialysis.They are
1)The dialyzer
2)The composition and  delivery of dialysate.
3)The blood delivery system.
8HAEMODIALYSIS MACHINE
9Dialyser:
The dialyser is a plastic chamber with the ability to perfuse blood and
dialysate compartments simultaneously at very high flow rate. The hollow
fiber dialyser is the most commonest in use. These  dialysers are made of
bundles of capillary tubes through which blood flows while the dialysate
travels on the outside of the fibers.
DIALYSATE
The dialyser is where the blood and dialysis solution circuits interact
and where the movement of molecules between dialysis solution and blood
across a semipermeable membrane occurs. The  dialyser shell is a box or tube
with four ports. Two ports communicate with a blood compartment and other
two ports with a dialysis solution. The membrane present in the dialyser
separates the two compartments.
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Structure:
Hollow fiber dialyser:
In this type, the blood flows into a chamber at one end of the
cylindrical shell called header, from there blood enters through the small
capillaries tightly bound in a bundle. The dialyser is designed so that blood
flows through the fibers and dialysis solution flows around the outside.
Hollow fiber dialyser
When blood flows through the capillaries, the blood collects in a header at the
other end of the cylindrical shell and is then routed back to the patient through
venous tubing and venous access device.
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Parallel plate dialyser:
In this type ,blood and dialysis solution pass through alternate spaces
between the membrane sheets.
PARALLEL PLATE DIALYSER
Membranes:
The  majority of  clinically used dialysers utilise a membrane
manufactured from synthetic polymer blends .the membranes are made of any
one of the following substances. They are
 polysulfone,
 polyethersulfone,
 polyacrylonitrile (PAN)
 polyamide and
 polymethylmethacrylate.
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Synthetic membranes  are more biocompatible than the earlier used cellulose
membranes.
Cellulose membranes are made up of molecular chains that contain
hydroxyl (OH) groups. These groups were  responsible for the poor
biocompatibility of the  membranes as it activated the complement system.
Coated membranes :
Improved biocompatibility resulted from the coating of the membrane
with an antioxidant such as vitamin E. It improved anti oxidant profile in the
blood of patients.
Dialysate composition:
potassium 0-4 mmol / L
Calcium 1.25 – 1.75 mmol/ L
Sodium 136-145 mmol/ L
Magnesium 0.25- 0.35 mmol/ L
Chloride 98-124 mmol/ L
Glucose 0-1 mg/dl
PH 7.1- 7.3
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Acetate 3.8MM
Citrate 0.8 – 1.0
Bicarbonate 25.35 MM
3)Blood Delivery system:
The blood delivery system consists of an extracorporeal circuit and
the dialysis access. The dialysis machine is composed of safety monitors,
dialysis solution delivery apparatus and blood pump. The role of  dialysis
solution delivery system is to dilute the concentrated dialysate system  with
water ,temperature monitoring, and to maintain the flow of the dialysate. The
fluid removal depends on the varying ultrafiltration coefficient of the
membrane.
Types of catheters:
Catheters are an important option for vascular access. They can be used
immediately after insertion, can be used for long periods of time and provide
painless haemodialysis access. There are multiple reasons for the high
prevalence of catheter use,
1)Increasing age of patients initiating haemodialysis,
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2)Increasing number of comorbid condition including significant vascular
disease,
3)Inadequate preparation prior to the need to initiate haemodialysis,
4)Scheduled living donor transplant,
5)When arterovenous fistula or graft is maturing or healing,
6)When a peritoneal dialysis catheter is planned.
The relationship between the type of catheter material and the risk for
bloodstream infection has been proved. Catheter made up of Teflon has less
chance of infection
1)Non tunnelled HD catheter:
Single- or double-lumen catheters  are  made of polymers ,such as
polyethylene or polyurethane. They  enable  simple and direct implantation of
the catheter easier. The catheter length  varies according to the site of
insertion.
The femoral route requires catheters of 30 to 35 cm in length for  distal tip to
be located in  inferior vena cava. The internal jugular vein route needs shorter
catheters of 20 to 25 cm in length, with tip location at the inferior vena cava–
right atrium junction. The subclavian vein should not be used due to high risk
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of venous stenosis. For sufficient blood flow rates through  the catheters,
diameter of these catheters must be ideally 12 to 14 French.
2)Tunneled catheters:
Tunneled central venous catheters have two lumens, measuring  a length
of 40 cm each,10 cm of the catheter is tunneled under the skin. Tunneled
catheters are made of synthetic polymer with  large internal lumen  and a
Dacron cuff to allow anchoring in the subcutaneous plane  The catheter
characteristics depends on the type of polymer used, design, and geometry -
double-lumen catheters or  dual catheters or split catheters .
Anti microbial impregnated catheter has less infection.Types of Anti
microbial impregnated catheters are chlorhexidine-silver sulfadiazine-coated
catheters and minocycline-rifampin-coated catheters. Incidence of infection
can be reduced by the use of silver-impregnated collagen cuff
catheters. Heparin-bonded catheters reduce catheter thrombosis and catheter
related infection.
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NON TUNNELED CATHETER
These temporary catheter are typically used when vascular access is
required for urgent renal replacement  therapy. In case of Acute kidney injury,
when duration of RRT is unpredictable, NTHC are the recommended as the
initial choice. But they are associated with the increased risk of
complications.
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Advantages of ultrasound use for NTHC insertion :
NTHC Site Advantages
Internal jugular
Vein
Reduces the risk arterial punctures, hematomas.
Faster catheter insertion ,time saving.
Femoral vein Significant reduction in complications
Increased first-attempt successful catheter insertion
Subclavian vein Should be performed by personnels experienced with this
approach
Optimal site selection for catheterization:
The following are the optimal sites for catheter insertion ,
Right  Internal jugular vein,
Femoral Vein ,
Left  Internal jugular vein,
Left subclavian vein with preference for the dominant side.
18
TUNNELED CATHETER
Contraindications to tunnelled catheter insertion:
INR >1.5
Platelet count <50 x 10 9/c
Active septicemia
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Catheter insertion site:
Venous catheter access:
Patients undergoing dialysis through arterovenous access do better than
those with venous catheters. The latter type have more chance of infections as
evidenced by higher levels of inflammatory markers like c- reactive protein.
survival rate of catheter decrease with the longer duration of catheter.
Another important problem with the venous catheters are inadequate flow .
Normal flow rate in venous catheter is 300ml/min, whereas the expected flow
rate is >400ml/min. These factors reduce the use of venous catheters in larger
proportion of patients. Ideally the catheter should be inserted on the opposite
side of a maturing planned arteriovenous access .Common femoral vein can
be used when the central veins are occluded. The catheter must be greater
than 20cm in length to minimize recirculation but >35 cm should be avoided
as flow rate decreases with increasing catheter length.
Venous catheters can be used as a long term access site in individuals where
AV access could not be created easily.
For example,
* in children,
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*in diabetic patients with peripheral arterial disease,
*overweight individuals,
*non availability of additional access site,
* in cardiomyopathy patients those who are not able to maintain the flow rate
adequately due to low blood pressure,
*long term use of venous catheters for haemodialysis has been accepted in
elderly patients with co-morbidities and reduced expectancy of life.
Strict disease control protocols like hand washing and catheter care protocols
for reducing the infection of the catheter
Characteristics of an Ideal vascular  access:
An ideal vascular access should have the following characteristic features,
1) maintain high blood flow rate
2) instant usability
3) long survival
4) low thrombosis rate
5) low infection rate
6) patients comfort
7) minimal cosmetic effect
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Insertion technique:
Informed written consent is  required before  catheter insertion.
Catheter insertion should be done under strict aseptic precautions. Sterile
gloves ,apron should be worn .An ultrasound examination should be done
over the selected site to make sure the veins are suitable for catheterization.
Ultrasound probe should be covered with sterile sheath. Insertion site and
surrounding areas should be cleansed with the surgical scrub and draped with
sterile clothes.
Internal jugular approach:
The ultrasound probe can be placed either parallel or perpendicular to the
long axis of the vessel. Perpendicular placement of the probe show the vein as
a circle but the needle is not visualised. In parallel placement , needle should
be inserted adjacent to the end of the probe. One should be able differentiate
the internal jugular vein from the carotid artery as they are closely related to
each other. We can differentiate them by applying gentle pressure of the probe
which causes the collapse of the vein. In addition, the diameter of the vein
increases on performing valsalva  manuever. We should avoid catheter
insertion through the muscle as this causes catheter dysfunction when the
head is rotated.
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After infiltration with the local anaesthetic agent,with the use of real time
ultrasound guidance ,a 21G micropunture needle with an attached syringe is
inserted into the vein because this type of needle has less complications if
inadvertently inserted into the carotid artery. Guide wire is inserted through
the needle and its position is confirmed by fluoroscopy.
The needle is removed after guidewire insertion and a 5F dilator is advanced
over the wire. The dilator has a slow switch to prevent air embolism. . There
should be a suture at the exit site and closure suture at the puncture site.
Puncture site sutures can be removed   in 10-14 days. The exit site suture can
be removed after 3 weeks.
Uncuffed catheter insertion :
For inserting an uncuffed temporary catheter, guidewire is advanced
into the vein and 5F dilator is removed and then serial dilators of increasing
size are passed over the wire to dilate soft tissue and venous tract
progressively. The dilator should move freely over the guidewire  and should
not be forcefully advanced as it can impinge and cause perforation of the vein
and the mediastinum. After inserting ,a check x-ray should be taken to
confirm the position of the catheter. In case if long term dialysis is required
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,the temporary non cuffed type catheter can be converted into tunnelled
catheter if there is no exit site infection.
Cuffed catheter insertion:
Dual lumen, large diameter catheter made  of silastic elastomers of
polyurethane  or silicone  are commonly used. A small incision is made from
the 5F dilator exit site extending laterally. A blunt dissection is done to the
surrounding subcutaneous tissue to create a pocket for the catheter to bend
without kinking. The cuff should be within the tunnel approximately 1-2 cm
from the exit site after accurate placement of the catheter using the guidewire.
Once the catheter exit site is identified ,the area is infiltrated with the local
anaesthetic and using 11 knife blade ,a puncture is made through the skin with
the widest  point of the blade. The tunnel tract is infiltrated with the long
needle from the exit site to the venotomy site. The catheter is then mounted
on the tunnelling device and is then pulled from the exit site subcutaneously
to the insertion site. The cuff is pulled into the tunnel and then the tunnelling
device is removed from the catheter.
Percutaneous trans lumbar insertion into inferior vena cava,
transhepatic, external jugular catheter can be considered if other venous sites
are not accessible.
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Catheter care:
1)Dressing:
During catheter handling, both the dialysis staff and the patient should
wear surgical masks. The catheter tips and lumen should never remain in open
air. A cap or syringe should be placed on or in the lumen of catheter while
maintaining a clean field under the catheter connectors. After each session of
dialysis ,the catheter hubs should be soaked in povidone iodine for 3-5
minutes.
Locking solutions:
After the dialysis session ,the dead space of each lumen is filled with
heparin 5000u/ml. Use of higher heparin concentration may result in high risk
of bleeding. The dead space of each catheter lumen varies among the length
of the catheter and manufacturers. The volume of heparin is usually labeled in
the hub of the catheter. Before each dialysis session, the heparin in the lumen
is aspirated ,the catheter is flushed with heparinised saline and dialysis
initiated.
Citrate is used as the anticoagulant as it chelates calcium, which is
essential for clotting to occur. Citrate can be used with a wider range of
antibiotic solutions. Very high concentration of citrate should not be used due
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to risk of inadvertent injection leading to hypocalcemia and precipitating
cardiac arrhythmia.
Bathing and showering:
The exit site should never be immersed in water. showering can be
done only after the exit site sinus tract is formed.
Exit site care:
Use of a sterile gauze or semipermeable dressing to cover the catheter
exit site will prevent the infection. Mupirocin ointment application has been
shown to reduce exit site infections and catheter related bacteria.
Complications of catheter insertion:
Mechanical complications due to catheter insertion are common .They
are arterial puncture
 hematoma
 pneumothorax
 pneumopericardium
 air embolism
Blood loss occurs, fatal bleeding like retroperitoneal bleeding occur in
approximately 0.5% of femoral insertions.
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Cardiac arrhythmias are potentially serious complications of all central
venous catheter insertion that typically relate to the insertion of the guide wire
used to insert the catheter by the seldinger technique. Patients with AKI are at
increased risk of serious ventricular arrhythmias during catheter insertion
compared to the patients with ESRD or normal renal function.
Long term mechanical complications :
High risk of central venous stenosis, with NTHC insertion into
subclavian vein. So catheter insertion into the subclavian vein is avoided
whenever possible. The risk of stenosis may be related to the extent of direct
contact between the catheter side wall and injury to the vascular endothelium.
NTHC are most frequently used in critically ill patients, the catheter related
complications may be attributed to concurrent illness of the patients.
Infectious Complications of  catheter insertion:
Higher risk of infection compared with both tunneled hemodialysis
catheters and nontunneled central venous catheter. CRBSI occurred higher
and once suspected there is need for NTHC removal.
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Catheter associated infections
 Central venous catheter associated infections are Catheter-related
bloodstream infections, exit-site infections, and tunnel infections .
 Catheter-related bloodstream infection (CRBSI) is defined as the
presence of bacteremia originating from an intravenous catheter .
 Infections are more common among patients in chronic kidney disease
on chronic hemodialysis.
 Hemodialysis patients with the catheter have  two to three fold
increased risk of hospitalization for infection and death than  the
patients with an arteriovenous fistula or graft.
 Hemo study proves that switching  from  central  venous  catheters  to
AV  fistulas  decreases  the  relative  mortality  risk in chronic
hemodialysis patients..
 The  increased  mortality  risk  is  due to  infection  and sepsis
associated with the  central  venous  catheter.
 Typically  infection  rates  are  three  episodes  of  infection  per  1000
tunneled  catheter–days  and  higher  with  non-tunneled  catheters.
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 Catheter associated localized  infections  can  progress  to  metastatic
complications like osteomyelitis,  septic  arthritis,  epidural  abscess,
endocarditis , brain abscess , septic pulmonary emboli.
Risk factors
 The most important risk factor  is prolonged duration of  catheter .
 Type of catheter , site of insertion , underlying disease, method of
catheter insertion,  purpose of catheterization.
 Local risk factors like poor personal hygiene, occlusive transparent
dressing, moisture around the exit site, Staphylococcus aureus nasal
colonization, and secondary infections like urinary tract infection..
 Other risk factors for are history of previous catheter-related bacteremia,
recent surgery, elderly patients, diabetes mellitus, iron overload,
immunosuppression,  hypoalbuminemia , chronic kidney disease , anemia,
patients on total parental nutrition.
Diagnosis:
The diagnosis of catheter related infection is mainly based on clinical features
and confirmation by laboratory investigations like blood culture and catheter
tip culture.
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Clinical features
 Fever and chills are the most sensitive clinical features. They are
associated with positive blood cultures in 60% to 80% of patients.
 Only some   patients with CRBSIs will have purulent discharge at
insertion  site and concurrent exit-site or tunnel infection.
 Other clinical manifestations are hemodynamic instability, altered
mental status, catheter dysfunction, hypothermia, nausea,vomiting,
and generalized malaise.
 Complications associated with  bloodstream infection like suppurative
thrombophlebitis, endocarditis, septic arthritis, osteomyelitis, epidural
abscess, may  be the first clue to the presence of catheter-related
bacteremia.
Laboratory diagnosis of catheter related bloodstream infections
The diagnosis of CRBSI requires  positive culture of blood obtained from
peripheral vein and clear evidence that the catheter is the source .
 Concurrent positive blood cultures of the same organism from the
catheter and a peripheral vein, with the colony count or differential time
to positivity meeting certain criteria.
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 Culture of the same organism from both the catheter tip and at least one
percutaneous blood culture.
 Cultures of the same organism from two peripherally drawn blood
cultures and an absence of an alternate focus of infection.
Clinical definitions
There are several definitions for CRBSI which are common in practice..
Kidney Disease Outcomes Quality Initiative (KDOQI)
Definite: Same organism from a semiquantitative culture of the catheter tip
(>15 CFU/catheter segment) and from a Blood culture  in a symptomatic
patient with no other apparent source of infection.
Probable: Defervescence of symptoms after antibiotic therapy with or without
removal of the catheter, in the setting in which BC confirms infection, but
catheter tip does not (or catheter tip does, but blood does not) in a
symptomatic patient with no other apparent source of infection.
Possible: Defervescence of symptoms after antibiotic treatment or after
removal of catheter in the absence of laboratory confirmation of BSI in a
symptomatic patient with no other apparent source of infection.
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Center for disease control and prevention (CDC)
Clinical manifestations and at least one positive Blood culture from a
peripheral vein and no other apparent source, with either positive
semiquantitative (>15 CFU/catheter segment) or quantitative (>103
CFU/catheter segment) culture, whereby the same organism (species and
antibiogram) is isolated from the catheter segment and a peripheral blood
sample.
Simultaneous quantitative cultures of blood samples with a ratio of ≥3:1
(catheter vs peripheral) .
Differential period of catheter culture versus peripheral BC positivity of 2 h.
OR
Isolation of the same organism from semiquantitative or quantitative culture
segment and from blood (preferably from a peripheral vein) of a patient with
accompanying symptoms of BSI and no other apparent source of infection.
Exit site infection :
Hyperemia, induration, and tenderness ≤2 cm from catheter exit site.
May be associated with fever and purulent drainage from the exit site. It may
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or may not be associated with bacteremia. If there is purulent drainage, it
should be collected and sent for Gram staining and culture.
CDC—Erythema or induration within 2 cm of the catheter exit site, in the
absence of concomitant BSI and without concomitant purulence.
EXIT SITE INDURATION
Tunnel infection
Tenderness, hyperemia, and/or induration that extends >2 cm from the exit
site and along the subcutaneous tunnel. It may or may not be associated with
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bacteremia. If there is purulent drainage, it should be collected and sent for
Gram staining and culture.
CDC—Tenderness, erythema, or site induration >2 cm from the catheter site
along the subcutaneous tract of a tunneled catheter, in the absence of
concomitant BSI.
TUNNEL INFECTION
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Blood cultures :
Specimen collection
 Blood samples  are drawn from the catheter and a peripheral vein for
culture before the  initiation of antibiotic therapy.
 If the  blood sample cannot be drawn from the peripheral vein, then blood
can be drawn from different lumens of multilumen catheters.
 If this approach is used  more than two blood samples should be drawn
through catheter lumens at different times
Catheter culture
 Catheter cultures should be performed for suspected CRBSI
 Central venous catheters are  evaluated by culturing the tip if the device
has been in place for atleast 7 to 10 days.
 If catheter is in place for less seven days - intradermal portion  of
catheter can be cultured  because the etiology of infection in these patients
is most due to infection of the catheter wound.
 If the catheter is an implanted device the tip should be cultured
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 Pulmonary artery catheters should be evaluated by culturing the
introducer
 Catheter tips with antimicrobial coating  like silver
sulfadiazine or chlorhexidine should be cultured with specific inhibitors
in the culture media
 The distal 5 cm of the central venous catheter tip was collected  in a sterile
test tube and transported immediately to the lab for culture.
 Immediately  after catheter removal, 5 ml of blood was collected from
peripheral vein in trypticase soy broth for blood culture.
Culture media
The catheters were cultured using three methods of catheter segment
cultures: semi-quantitative, quantitative, and qualitative.
In semi quantitative method distal 5 cm of catheter segment is rolled
across Blood agar plate four times with downward pressure
After SQC, the segment was immersed in trypticase soya broth. The plate was
incubated at 37°C and colony count was recorded after 48 h. For qualitative
culture, trypticase soya broth containing catheter segment was incubated as
37°C and then subcultured on Blood agar and MacConkey's agar plates after
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24, 48 and 72 h. The plates were incubated for 24 h at 37°C. Blood collected
from the peripheral vein in trypticase soya broth for qualitative culture was
incubated at 37°C. Subcultures were made on Blood agar and MacConkey's
agar plates after 24, 48 and 72 h. The plates were incubated for 24 h at 37°C.
All the colonies grown were examined for the morphology followed by Gram
staining and were identified by standard methods of Koneman.
Antibiotic susceptibility testing was performed for all isolates on Muller-
Hinton agar. The susceptibility test was done by the standard Kirby Bauer
disc diffusion method. The selection of antibiotic for sensitivity was based on
the National Committee for Clinical Laboratory Standards (NCCLS)
guidelines and suggestions of clinicians
Microbiology
 Most common organism related with catheter related infection is
staphylococcus aureus..
 Polymicrobial - 16%
 Gram positive - staph aureus , staph epidermis ,MRSA, enterococcus ,
corynebacterium
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 Gram negative - enterobacter , pseudomonas, acinetobacter, klebsiella,
citrobacter , serratia.
Staphylococcus aureus
 Staphylococcus aureus is a gram-positive bacteria , they are cocci-shaped
and arranged in clusters (“grape-like”).
 On  culture media, these organisms can grow in up to 10% salt, and
colonies are often golden or yellow colour .
 It is a normal commensal in skin , nose , respiratory tract..
 They can grow aerobically and anaerobically at temperatures between 18C
and 40 C.
 Biochemical identification tests  for staphylococcus are catalase
test,nitrate reduction, coagulase test, sensitivity to novobiocin, mannitol
fermentation.
 All pathogenic Staphylococcus species are catalase positive , to
distinguish Staphylococcus aureus from other Staphylococcus species
coagulase test is used. Staphylococcus aureus species are coagulase
positive.. novobiocin sensitivity will be present in
38
Staphylococcus saprophyticus, and mannitol fermentation is used to
distinguish from Staphylococcus epidermidis
Staphylococcus aureus
.
Klebsiella pneumoniae
 Klebsiella is a Gram-negative, oxidase-negative, rod-shaped bacteria with
a prominent polysaccharide capsule
 Klebsiella species are found everywhere in nature. They can be found in
water, soil, plants, insects . It is the second most aerobic bacterial flora of
human intestine.
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 It is also called as Friedlander bacillus , bacillus capsulatus.
 They are short , straight rods .
 It ferments sugars like glucose , lactose , sucrose, mannitol with
production of acid and gas.
 They have no specific growth requirements and  they grow well on
standard laboratory media,  between 35 and 37 °C and at pH 7.2. They
produce mucoid colonies
 It is Indole and methyl red negative , Vokes - Proskauer and citrate
positive
 They have been classified into three species k.pneumoniae , k.ozaenae,
k.rhinoscleromatis.
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Klebsiella pneumoniae
Enterococcus
 Enterococci are Gram-positive cocci that often occur in pairs
(diplococci) or short chains.
 They are part of the normal commensal flora of the gastrointestinal
tract
 They grown in the presence of 40 percent bile , 6.5 percent sodium
chloride, at pH 9.6 at 45 degree Celsius and 0.1 percent methylene
blue milk.
 On Mac conkeys  medium they produce tiny deep pink colonies
 They are heat resistant and usually non haemolytic.
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Enterococcus
Prevention of CRBSI
Educational programs  regarding hand hygiene and written protocols
concerning catheter insertion - preparation of the equipment, skin
antisepsis,  strict aseptic insertion techniques , catheter manipulation  ,
catheter care and Staff education and health care quality improvement.
 Catheters should be inserted under strict aseptic conditions.
 The right internal jugular vein position is the most  preferred location for
insertion, followed by the left internal jugular vein position.
 The use of femoral vein  is usually discouraged.
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 The use of the subclavian vein position is discouraged due to frequent
stenosis.
 Choosing appropriate sites for catheter insertion
 Using the appropriate type of catheter material
 Using barrier precautions during insertion
 Changing catheter administration sets at appropriate intervals
 Ensuring proper catheter site care
 Ensuring removal of catheters when no longer essential
 The use of ultrasound guidance method to insert central venous catheter
reduce the risk of complications  and infections during central venous
catheterization. In this technique, an ultrasound probe is used to localize
the vein and it measures the  depth  of vein beneath the skin.
 Use the CVC with minimum number of ports
Site care :
Insertion site preparation
 Use of antiseptic solution for skin disinfection at the catheter insertion site
prevents  catheterrelated infection.
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 Chlorhexidine-based solutions are superior to both aqueous and alcohol-
based povidone-iodine in reducing the risk for catheter colonization and
catheter-related bloodstream infection
Sterile technique
 While inserting the catheter one should use maximal sterile-barrier
precautions, including mask, cap,  sterile  long -sleeved gown, sterile
gloves, and a large sterile drape.
Tunneling
 Subcutaneous tunneling  CVCs  reduces the incidence of catheter
infection, by increasing the distance between the venous entry site and
skin .
 Tunneling of catheter gives better fixation.
Exit site dressing
 The catheter exit site should be covered by dressing as long as the catheter
is in the place.
 The exit site should be inspected at every hemodialysis session, and the
exit-site dressing should be replaced on a routine basis if it’s not clean
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 The patient should be instructed to maintain the hygiene and integrity of
the dressing.
 The two most common types of dressing used are sterile, transparent,
semi-permeable polyurethane dressings coated with layer of an acrylic
adhesive, and gauze &tape dressings.
 Transparent, semipermeable polyurethane dressings allow continuous
visual inspection of the site,require less frequent changes than do standard
gauze and tape dressings
 If blood is oozing from the catheter insertion site, a gauze dressing may be
preferred.
Topical antimicrobials
 Antimicrobial application to exit site with dressing can reduce catheter-
related infections
 Mupirocin ointment , povidine iodine ointment are commonly used.
Antibiotic locks
The antibiotic lock technique for prevention of CVC-related infection
includes filling of the catheter lumen with high concentrations of antibiotics
for several hours in order  to prevent colonization of the intraluminal surface
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of the catheter. The main complication with the prolonged use of
antimicrobial lock solutions are the potential development of antimicrobial
resistance
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MATERIALS AND METHODS
Materials :
Patients undergoing haemodialysis via central venous catheters in the
dialysis unit of our institution were included in the study.
Duration of study :1 year
Type of study : Prospective study
Sample size : 75
Inclusion criteria:
1.patients undergoing haemodialysis via central venous catheters
Exclusion criteria :
1.patients undergoing haemodialysis via arteriovenous fistula
2.patients with cellulitis and other focus of infection
Methodology:
Demographic data and clinical variables including age, sex, duration of
dialysis, site of catheter insertion, diabetes, and nutritional status  for each of
the patients were collected at the initial visit .Patients with symptoms and
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signs of catheter related infection like fever, chills, hypotension ,local catheter
site infection are subjected to blood cultures .One from the peripheral vein
and the other from the central venous access .Catheter tip were also subjected
to semi quantitative analysis in sterile container.
Statistical analysis :
Categorical variables were reported as numbers(percentage).Chi-square test
was used for univariate analysis for factors in relation to catheter related
infections
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OBSERVATION AND RESULTS
Age Distribution
Table 1
Age group Frequency Percent
20-30 13 17.3%
30-40 13 17.3%
40-50 18 24.0%
>50 30 40.0%
Total 75 100.0
Chart 1
In our study, 40% of the patients were in the age group of more than 50 years.
20-30 yrs, 17.3%
30-40 yrs, 17.3%
40-50 yrs, 24.0%
>50 yrs, 40.0%
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Gender Distribution
Table 2
Gender Frequency Percent
Male 62 82.7%
Female 13 17.3%
Total 75 100.0
Chart 2
In our study, about 82.7% of the patients were males and 17.3% of the
patients were females.
Male
83%
Female
17%
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Number of Diabetic Patients
Table 3
Diabetes Frequency Percent
Non diabetic 38 50.7%
Diabetic 37 49.3%
Total 75 100.0
Chart 3
Among the study population, 37 patients were diabetic.
36
37
37
37
37
37
38
38
38
Non diabetic Diabetic
38
37
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Type of Kidney Disease
Table 4
Type of Kidney
disease Frequency Percent
AKI 15 20.0%
CKD 60 80.0%
Total 75 100.0
Chart 4
Among 75 patients, 60 patients were suffering from Chronic Kidney disease
and 15 patients were suffering from Acute Kidney Injury.
AKI
20%
CKD
80%
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Hemoglobin level among study population
Table 5
Hb Frequency Percent
<6 22 29.3%
6 to 10 36 48.0%
>10 17 22.7%
Total 75 100.0
Chart 5
In our study population,22 patients had Hb less than 6; 36 patients had Hb 6
to 10; 17 patients had Hb greater than 10 g/dl.
<6
6 to 10
>10
0 10 20 30 40
22
36
17
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Albumin level among study population
Table 6
Albumin Frequency Percent
<3
36 48.0%
>3
39 52.0%
Total
75 100.0
Chart 6
In our study population,36 patients had albumin less than 3 g; 39 patients had
albumin  more than 3.
<3, 36
>3, 39
36
36
37
37
38
38
39
39
40
0 0.5 1 1.5 2 2.5
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Catheter insertion site
Table 7
Catheter site Frequency Percent
Femoral 56 74.7%
Jugular 19 25.3%
Total 75 100.0
Chart 7
Among 75 patients, 56 had  catheter insertion in the jugular vein and 19
patients had catheter insertion in the femoral vein.
Femoral
75%
Jugular
25%
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Catheter duration
Table 8
Duration of catheter Frequency Percent
<14days
37 49.3%
>14 days
38 50.7%
Total
75 100.0
Chart 8
Among 75 patients, 37 patients had central venous catheter for less than 14
days and 38 patients had catheter for more than 14 days.
<14days, 37,
49%
>14 days,
38, 51%
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BMI
Table 9
BMI Frequency Percent
<18 31 41.3%
18-25 43 57.3%
>25 1 1.3%
Total 75 100.0
Chart 9
Among our study population, 31 patients had BMI less than 18 and 43
patients had BMI 18 to 25.
0
5
10
15
20
25
30
35
40
45
<18
18-25
>25
<18, 31
18-25, 43
>25, 1
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Number of fever patients
Table 10
Fever Frequency Percent
Afebrile
36 48.0%
Febrile
39 52.0%
Total
75 100.0
Chart 10
Out of 75 patients with CVCs, 39 patients had fever episodes.
Series1,
Afebrile, 36,
48%
Series1,
Febrile, 39,
52%
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Blood pressure during Hemodialysis
Table 11
Blood Pressure Frequency Percentage
Normotension 42 56.0%
Hypotension 33 44.0%
Total 75 100.0
Chart 11
In our study, about 33 patients are hypotensive and about 42 were
normotensive.
0
10
20
30
40
50
Normo tension
Hypo tension
42
33
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Catheter site infection
Table 12
Catheter site infection Frequency Percent
No infection 43 57.3%
Infection 32 42.7%
Total 75 100.0
Chart 12
In our study, about 32 patients had local catheter site infection.
0%
20%
40%
60%
80%
100%
No infection
Infection
43
32
60
Catheter site skin swab culture
Table 13
Culture Frequency Percentage
Positive 31 41.4
Negative 44 58.6
Total 75 100
Chart 13
Among 75 patients, 31 patients had catheter site skin swab culture growth.
Positive
Negative
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Type of organism in catheter insertion site
Table 14
Staining Frequency Percent
Negative 4 5.3%
Positive 27 36.0%
Total 31 41.3%
Chart 14
The organism isolated from pericatheter insertion site were mainly
Gram positive organisms.
Negative
Positive
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Blood culture
Table 15
Blood culture Frequency Percent
Negative 52 69.3%
Positive 23 30.7%
Total 75 100.0
Chart 15
In our study, 23 patients showed growth in the blood culture.
0
20
40
60
Negative
Positive
52
23
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Gram staining in Blood culture
Table 16
Organism staining Frequency Percent
Negative 10 13.3%
Positive 13 17.3%
Total 23 30.6%
Chart 16
Of 23 patients who were Blood culture positive, 13 patients showed
gram positive organism on staining.
0 2 4 6 8 10 12 14
Negative
Positive
10
13
64
Type of Organism
Table 17
Chart 17
The main organisms isolated were S.aureus (17.3%), Klebsiella
(9.31%), and Pseudomonas(3.99%).
Frequency
0
5
10
15
S.aureus Klebsiella Pseudo
13
7
3
Type of organism Frequency Percent
S.aureus 13 17.3%
Klebsiella 7 9.31%
Pseudomonas 3 3.99%
Total 23 30.6%
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Catheter tip culture
Table 18
catheter tip culture Frequency Percent
Negative 52 69.3%
Positive 23 30.7%
Total 75 100.0%
Chart 18
In our study, 23 patients showed growth in the catheter tip culture and
remaining 52 showed no growth.
0
10
20
30
40
50
60
70
80
Negative
Positive
Total
52
23
75
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Catheter tip culture gram staining
Table 19
gram stain Frequency Percent
negative 9 12.0%
positive 14 18.7%
Total 23 30.7%
Chart 19
Of 23 patients who were catheter tip culture positive, 14 patients
showed gram positive organism on staining.
0
5
10
15
negative
positive
9
14
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Type of organism in catheter tip
Table 20
Type of organism Frequency Percent
S.aureus 14 18.7%
Klebsieela 9 12.0%
Total 23 30.7%
Chart 20
The main organisms isolated were S.aureus (18.7%) ,and  Klebsiella
(12%)
S.aureus
Klebsieela
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Association of Diabetes vs. Culture positivity in blood
Table 21
Blood culture
Total P valueNegative Positive
Non diabetic 36 2 38
<0.0001Diabetic 16 21 37
Total 52 23 75
Chart 21
Out of 23 patients who are positive for blood culture, 21 patients were
diabetic.(P value=<0.0001). So there is a significant association between
Diabetes and blood culture positivity.
36
2
16
21
0
5
10
15
20
25
30
35
40
Negative Positive
Non diabetic
Diabetic
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Association of Albumin vs. Culture positivity in blood
Table 22
Blood culture
Total P valueNegative Positive
Albuminemia <3 18 18 36
<0.0001>3 34 5 39
Total 52 23 75
Chart 22
Out of 23 patients who are positive for blood culture, 18 patients were
found with serum albumin less than 3.(P value=<0.0001). So there is a
significant association between hypoalbuminemia and blood culture
positivity.
18 18
34
5
0
5
10
15
20
25
30
35
40
Negative Positive
<3
>3
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Association between sites of catheter insertion vs. Culture positivity in blood
Table 23
Blood culture
Total P valueNegative Positive
Catheter
Type
Femoral 39 17 56
Jugular 13 6 19 0.921
Total 52 23 75
Chart 23
There is no significant association between Catheter site insertiom and
blood culture positivity(P value=0.921).
39
17
13
6
0
5
10
15
20
25
30
35
40
45
Negative Positive
Femoral
Jugular
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Association between duration of catheter insertion vs. Culture positivity in
blood
Table 24
Blood culture
Total P
valueNegative Positive
Duration of catheter
<14days
>14 days
31 6 37
21 17 38 0.007
Total 52 23 75
Chart 24
Out of 23 patients who are positive for blood culture, 17 patients had
catheter more than 14 days.(P value=<0.007). So there is a significant
association between duration of catheter insertion and blood culture positivity.
31
6
21
17
0
5
10
15
20
25
30
35
Negative Positive
<14days
>14 days
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Association between febrile episodes vs. Culture positivity in blood
Table 25
Blood culture
Total P valueNegative Positive
Fever Afebrile 32 4 36
<0.0001Febrile 20 19 39
Total 52 23 75
Chart 25
Out of 23 patients who are positive for blood culture, 19 patients had
febrile episodes(P value=<0.0001). So there is a significant association
between febrile episodes and blood culture positivity.
32
4
20 19
0
5
10
15
20
25
30
35
Negative Positive
Afebrile
Febrile
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Association between Catheter site infections vs. Culture positivity in blood
Table 26
Blood culture
Total P valueNegative Positive
Catheter
site
infection
No
37 6 43
Yes 15 17 32 <0.001
Total 52 23 75
Chart 26
Out of 23 patients who are positive for blood culture, 17 patients
had catheter infection in the catheter site.(P value=<0.001). So there is a
significant association between catheter site infection and blood culture
positivity.
37
6
15 17
0
5
10
15
20
25
30
35
40
Negative Positive
No infection
Infection
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DISCUSSION
Haemodialysis catheter related infection is the major cause of mortality
and morbidity in haemodialysis. Identification of risk factors help in
preventing the catheter  related infection (suzan sanavi et al). To identify the
predisposing factors, we studied 75 patients out of which  82.7% are male and
37 patients had comorbidities like diabetes.
Among 75 patients 60 patients had  chronic kidney disease as the
indication for dialysis. Regarding the type of venous access , 56 patients had
femoral vein  catheterization  and 19 patients had jugular venous access.38
patients had catheter duration of more than 14 days.
Out of 75 patients ,febrile episodes occurred in 39 patients and
hypotension in 33 individuals. Local catheter site infection occurred in 32
patients and swab culture from catheter site showed growth in 31 patients.
Blood culture from both central venous access site and peripheral vein
showed growth of bacteria in 23 patients .The most common organism
isolated from the blood culture was gram positive staphylococcus
aureus(17.3%) followed by klebsiella (9.37%) and pseudomonas(3.99%).
Culture of the catheter tip by semi quantitative method showed growth
in 23 patients , among them the common organisms are gram positive. From
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our study ,we come to a conclusion that there is no significant association
between the site of catheter insertion and catheter related blood steam
infection in contrast to Lemaire et al .
Out of 23 patients who are positive for blood culture, 17 patients had
catheter infection in the catheter site.(P value=<0.001). So there is a
significant association between catheter site infection and blood culture
positivity.
Among 23 patients who are positive for blood culture, 19 patients had
febrile episodes(P value=<0.0001). So there is a significant association
between febrile episodes and blood culture positivity.
Out of 23 patients who are positive for blood culture, 17 patients had
catheter more than 14 days.(P value=<0.007). So there is a significant
association between duration of catheter insertion and blood culture positivity.
Among 23 patients who are positive for blood culture, 18 patients were
found with serum albumin less than 3.(P value=<0.0001). So there is a
significant association between hypoalbuminemia and blood culture
positivity.
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Out of 23 patients who are positive for blood culture, 21 patients were
diabetic.(P value=<0.0001). So there is a significant association between
Diabetes and blood culture positivity.
From our study we concluded that, Patients with diabetes and
hypoalbuminemia ,prolonged duration of catheter ,local catheter site
infection, and patients with febrile episodes during the haemodialysis has
significant association with the blood culture positivity compared  to previous
studies. Catheter related infection and blood stream infection during
haemodialysis is more with patients in Diabetes, malnutrition,and  prolonged
duration of catheter
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CONCLUSION
Out of 75 patients who were randomnly selected  based on the inclusion
and exclusion criterias, the following results were observed,
Blood culture positivity  was observed in 23 patients out of 75 patients who
had central venous catheter for haemodialysis (30.7% incidence). The
incidence of catheter related infection and blood stream infection is 30.7%.
The most common organism isolated was Gram positive organisms mainly
Staphylococcus aureus followed by Gram negative organisms Klebsiella.
Catheter related infection and catheter related blood stream related infections
showed significant association with the diabetes, hypoalbuminemia, local
catheter site infection and prolonged duration of catheterization
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PROFORMA
1.name
2.age                                                             3.sex
4.Diabetes     yes/no
5.type of kidney disease     CKD /AKI
6.Site of catheter insertion  jugular/ femoral
7.duration of catheter
8.clinical symptoms during dialysis fever    and chills          yes/no
Hypotension                 yes/no
Altered  sensorium       yes/no
Malaise                           yes/no
9.local catheter site  induration/swelling/pus discharge
10.culture from pericatheter site  :
11. type of organism gram positive/gram negative
12.blood culture from the venous access growth :positive/negstive
13 gram staining of organism from blood culture:  gram positive/gram negative
14 organism isolated from blood culture:
15 catheter tip culture:          positive /negative
16.organism from catheter tip :gram positive/gram negative
17.organism isolated from catheter tip culture:
18. inv : total count :
Hb:
Total serum protein:
Serum albumin:
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1 Murugan >50 M Y Y <6 <3 Jugular <14 <18 Y Y Y Posi (C+P) Positive S.aureus Positive S.aureus Positive Positive S.aureus
2 Pattathi >50 M Y Y 6-10 <3 Femoral >14 <18 Y Y Y Posi (C+P) Positive S.aureus Positive S.aureus Positive Positive S.aureus
3 Mugesh 20-30 M N Y >10 >3 Femoral >14 18-25 N N N Neg
4 Vairamuthu >50 M Y Y 6-10 <3 Femoral >14 18-25 Y Y Y Posi (C+P) Negative KlebsieelaPositive S.aureus Negative Negative Klebsieela
5 Sathiyaraj 20-30 M N Y >10 >3 Femoral >14 18-25 N N N Neg
6 Sudalaimuthu >50 M Y Y >6 <3 Femoral >14 <18.5 Y N N Neg
7 Vinothkumar 20-30 M N Y >10 >3 Jugular <14 18-25 N N N Neg
8 Chinapadi 30-40 M N Y >10 >3 Femoral <14 18-25 N N N Neg
9 Mariammal >50 F Y Y 6-10 <3 Femoral <14 18-25 N N N Neg
10 Chinnapandi 30-40 M N Y 6-10 >3 Femoral <14 18-25 N N N Neg
11 Karthick 20-30 M N Y >10 >3 Femoral <14 18-25 Y Y Y Posi (C+P) Positive S.aureus Positive S.aureus Positive Positive S.aureus
12 Arumugan 30-40 M Y Y >10 >3 Femoral <14 18-25 Y Y Y Posi (C+P) Negative KlebsieelaNegative K.seill Positive Negative Klebsieela
13 Joseph >50 M Y Y <6 <3 Femoral >14 >25 N Y N Posi (C+P) Negative KlebsieelaNegative Klbeslella Positive Negative Klebsieela
14 Selvam >50 M Y Y 6-10 >3 Jugular >14 18-25 N N N Neg
15 Murugan >50 M N Y 6-10 >3 Jugular >14 18-25 N N N Neg
16 Kannan >50 M Y Y 6-10 >3 Femoral >14 18-25 N N Y Neg Positive S.aureus - - -
17 Velusamy >50 M N Y 6-10 >3 Femoral >14 18-25 N N Y Neg Positive S.aureus - - -
18 Kathiresan >50 M Y Y <6 <3 Jugular >14 <18 N N N Posi (C+P) Negative Klebsieela Positive Negative Klebsieela
19 Manikandan 20-30 M N Y 6-10 >3 Femoral >14 18-25 N N N Neg
20 Paulthai 40-50 F Y Y 6-10 >3 Femoral >14 18-25 N N N Neg (C+P)
21 Padma >50 F Y Y <6 <3 Femoral <14 <18 Y Y N Pos (C+P) Positive S.aureus Positive Positive S.aureus
22 Jananeshan 30-40 M N Y 6-10 >3 Femoral <14 18-25 N N N Nega
23 Vinoth 20-30 M N Y >10 >3 Jugular <14 18-25 N N N Nega
24 Kalangaray >50 M Y Y 6-10 <3 Femoral <14 <18 N N Y Nega - - -
25 Saravanaraj 20-30 M N Y >10 >3 Jugular <14 18-25 N N N Nega
26 Lakshmanan >50 M N Y >10 >3 Femoral <14 18-25 N N N Nega
27 Kumar 20-30 M N Y >10 >3 Jugular <14 18-25 N N N Nega
28 Sakthivel 20-30 M N Y >10 >3 Jugular <14 18-25 N N N Nega
29 Selvaganesh 40-50 M N Y 6-10 >3 Femoral <14 <18 Y Y N Nega
30 Mariyaselvam 30-40 M N Y 6-10 <3 Femoral <14 18-25 Y Y Y Nega
31 Subaish 40-50 M N Y 6-10 <3 Femoral <14 18-25 N N N Nega
32 Ramrajan 40-50 M N Y 6-10 >3 Femoral <14 18-25 N N N Nega
33 Iruthyaselvi 40-50 F Y Y <6 <3 Jugular >14 <18 Y Y Y Posit (C+P) Negative Pseudo Negative Klbeslella Positive Negative Klebsieela
34 Ramraj 30-40 M N Y 6-10 >3 Femoral >14 <18 Y Y N Nega
35 Kaleeswari 26-30 F N Y >10 >3 Femoral <14 18-25 Y N N Neg
36 Anbu 30-40 M N Y >10 >3 Femoral <14 18-25 Y N Y Neg Positive S.aureus
37 Moses 20-30 M N Y >10 >3 Femoral <14 18-25 Y Y N Neg
38 Akbar 20-30 M N Y >10 >3 Femoral <14 18-25 Y Y N Neg
39 Dharmendra 30-40 M N Y >10 >3 Femoral >14 18-25 N N N Neg
40 Hanifa 40-50 M N Y >10 <3 Femoral >14 18-25 N N N Neg
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41 Esakki >50 F Y Y <6 <3 Femoral >14 <18 Y Y Y Pos (C+P) Negative Pseudo Positive S.aureus Positive Negative Klebsieela
42 Amutha >50 F Y Y <6 >3 Jugular >14 <18 Y Y Y Pos (C+P) Positive S.aureus Positive S.aureus Positive Positive S.aureus
43 Alaguraj 40-50 M N Y 6-10 >3 Femoral <14 18-25 N N N Neg
44 Ramachandran 40-50 M Y Y 6-10 >3 Femoral <14 18-25 Y N Y Neg
45 John >50 M Y Y <6 <3 Femoral <14 <18 Y Y Y Pos (C+P) Positive S.aureus Positive S.aureus Positive Positive S.aureus
46 Muthukumar >50 M Y Y 6-10 <3 Femoral <14 <18 Y Y N Neg
47 Balammal >50 F Y Y 6-10 >3 Femoral >14 18-25 N N N Neg
48 Pooraiah >50 M Y Y <6 <3 Femoral >14 <18 Y Y Y Pos (C+P) Positive Negative Klebsieela
49 Manthramoorthy >50 M Y Y <6 <3 Femoral >14 <18 Y Y Y Pos (C+P) Negative KlebsieelaPositive S.aureus Positive Negative Klebsieela
50 Chinnathai 40-50 F Y Y 6-10 >3 Femoral <14 18-25 N N Y Neg (C+P) Positive S.aureus
51 Murugan 40-50 M Y Y <6 <3 Jugular >14 <18 Y N Y Pos (C+P) Negative Pseudo Negative pseudomone Positive Negative Klebsieela
52 Balu 40-50 M Y Y <6 <3 Femoral >14 <18 Y Y Y Neg
53 Kalimuthu 30-40 M N Y 6-10 >3 Femoral <14 18-25 Y N N Neg
54 Aruna 30-40 F Y Y 6-10 >3 Femoral <14 18-25 Y Y N Neg
55 Naveenthan >50 M Y Y 6-10 >3 Femoral <14 <18 Y Y Y Neg positive S.aureus
56 Karunanthi 30-40 M Y Y <6 <3 Jugular >14 <18 N N Y Pos (C+P) Negative KlebsieelaPositive S.aureus Positive Positive S.aureus
57 Lawrence 20-30 M N Y 6-10 >3 Jugular >14 18-25 N N N Neg
58 Palani >50 M Y Y <6 <3 Femoral >14 <18 Y N N Pos (C+P) Positive S.aureus Positive S.aureus Positive Positive S.aureus
59 Sudalaimani 40-50 M N Y 6-10 <3 Femoral >14 <18 Y Y Y Neg
60 Sankaranainar >50 M Y Y <6 <3 Femoral >14 <18 N N Y Pos (C+P) Positive S.aureus Positive S.aureus Positive Positive S.aureus
61 Ramar >50 M Y Y 6-10 >3 Femoral <14 <18 Y Y Y Pos (C+P) Positive S.aureus Positive S.aureus Positive Positive S.aureus
62 Mundan 40-50 M Y Y 6-10 <3 Femoral <14 18-25 Y Y N Neg Positive s.aureus
63 Gurusamy >50 M Y Y <6 <3 Femoral >14 <18 Y Y N Pos (C+P) Positive S.aureus Positive S.aureus Positive Positive S.aureus
64 Gopalakrishnan 40-50 M N Y 6-10 >3 Femoral >14 18-25 Y Y Y Pos (C+P) Positive S.aureus Positive S.aureus Positive Positive S.aureus
65 Pandiyan 40-50 M Y Y 6-10 <3 Femoral >14 <18 Y Y Y Pos (C+P) Positive S.aureus Positive S. aureus Positive Positive S.aureus
66 Rubeela >50 F Y Y <6 <3 Femoral >14 <18 Y Y N Pos (C+P) Positive S.aureus Positive s.aureus Positive Positive S.aureus
67 Daisy >50 F N Y 6-10 <3 Jugular >14 18-25 N N N Neg
68 Marimuthu 40-50 M N Y 6-10 >3 Femoral >14 18-255 Y Y N Neg
69 Madasamy 40-50 M N Y <6 <3 Jugular <14 18-25 N N Y Neg Positive S.aureus
70 Pandiyan 40-50 M N Y <6 <3 Jugular <14 18-25 N N Y Neg Positive S.aureus
71 Romalaush 20-30 M N Y <6 <3 Jugular >14 <18 N N N Neg
72 Sankaran 30-40 M N Y 6-10 <3 Femoral >14 <18 N N Y Neg Positive S.aureus
73 Rubeela 30-40 F N Y 6-10 <3 Jugular <14 <18 Y Y N Neg
74 Balamurugan >50 M Y Y <6 <3 Femoral <14 <18 Y Y Y Neg Positive S.aureus
75 Gokul >50 M Y Y <6 <3 Femoral >14 <18 Y Y Y Neg Positive S.aureus
